As of 2025-09-18, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (161.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -30821.3%.
The range of the Relative Valuation is (129.89) - (181.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (129.89) - (181.99) | (161.78) |
| Upside | -24765.8% - -34658.7% | -30821.3% |
| Date | P/E |